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INTRODUCTION 
 
Esophageal lesions once thought to be a rare, is nowadays being 
one of the common disorder affecting the people throughout the world 
and one among the top ten malignant neoplasms affecting the people of 
Tamilnadu, ranking fourth in the gastrointestinal tract following 
stomach, colon and pancreas. 
 
Twenty percent of esophageal tumors are benign, mostly 
leiomyomas, remaining 80% are malignant tumors in which about 90% 
are squamous cell carcinoma. The depiction of carcinoma esophagus in 
one of the ancient Chinese literature as “one suffers in autumn and does 
not live to see the coming summer”, is no more considered true, due to 
recent diagnostic and therapeutic advances that have improved the short 
term prognosis of these patients. 
 
Esophageal cancer is a malignancy that is well known for its 
marked variation by geographic area, ethnic group and sex. It is one 
among the most dismal of visceral tumors, owing to their generally 
advanced stage at the time of diagnosis in developing countries. 
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A prospective study of patients presenting with dysphagia, loss of 
weight, anorexia, and regurgitation of food is undertaken to evaluate the 
relationship of this symptom complex to underlying esophageal lesions 
with special reference to Barrett’s esophagus. The clinical, endoscopic 
findings and histopathological evaluation of esophageal biopsy 
specimens with routine and special stains to demonstrate the underlying 
nature of lesion are presented. Regarding the histopathology, previous 
studies on the pathologic changes of esophageal mucosa induced by 
Gastrointestinal Reflux Disease (GERD) has been mainly focussed and 
analysed. 
Barrett’s Esophagus (BE) is a premalignant condition in which 
metaplastic specialized columnar epithelium with goblet cells replaces 
the normal squamous esophageal epithelium, which is closely associated 
with GERD, in which there is a significant progression from metaplasia 
to low-grade dysplasia to high-grade dysplasia and subsequently to 
adenocarcinoma.  
The prevalence of Barrett’s esophagus in the general population is 
difficult to estimate since most cases in the asymptomatic population 
remain undiagnosed. The prevalence is estimated to be about 18% and 
may be high as 36%. Estimates of incidence of Adenocarcinoma in 
patients with Barrett’s esophagus vary widely, but Barrett’s esophagus 
continuous to be a major health concern in most of the western countries 
where numerous surveys have provided information on its 
epidemiology, diagnosis, and surveillance strategy. 
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In semiurban areas like Thanjavur even though thought to be rare, 
the lifestyle and nutrition factors with alcohol, a major factor, proves to 
be vital in the occurrence of Barrett’s esophagus with subsequent 
adenocarcinoma. The esophagectomy specimens subjected for 
histopathological evaluation are also concentrated towards the 
histological type, morphological variants, presence or absence of 
changes in the upper gastric region and subsequent dysplastic changes at 
the adjacent mucosa. Resected studies and literature closely proves that 
CDC2 / CDK1, expression in esophageal adenocarcinoma and precursor 
lesions serve as a diagnostic and cancer progression marker and role of 
cytokeratin 7/20 in the Barrett’s esophagus. 
 
In the present study the histopathological features of Barrett’s 
esophagus is described in detail paying particular attention to the 
presence of goblet cells. In addition, the recent literature regarding 
epidemiology, clinical features, pathogenesis and pathology of 
esophageal lesions is reviewed. 
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AIM OF THE STUDY  
 
 
Esophagectomy and Endoscopic biopsy specimens were studied 
to find out the 
 
1. Role of socio-economic status, epidemiology and living 
conditions in the occurrence of esophageal carcinomas. 
 
2. Incidence of neoplastic and nonneoplastic esophageal lesions. 
 
3. To evaluate site of occurrence of esophageal carcinomas. 
 
4. To study the incidence of Barrett’s esophagus and subsequently 
Adenocarcinoma with mucin histochemistry.  
 
5. To evaluate the role of Immunohistochemistry in doubtful cases. 
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MATERIALS AND METHODS 
 
Patients presented with symptoms and signs of esophageal lesions 
referred from Thanjavur Medical College Hospital and Raja Mirasudar 
Hospital, Thanjavur which is attached to Thanjavur Medical College 
during January 2000 to September 2005 were included in this study. 
 
A thorough clinical evaluation, blood count, urine examination, 
Barium swallow and ultrasound abdomen (in proportion of cases) were 
done in each case. 
 
A detailed history with particular attention to socio-economic 
status, housing conditions, nutrition, alcoholism, smoking, tobacco and 
betel nut chewing and history of upper Gastrointestinal complaints in 
other family members were also recorded. 
 
ENDOSCOPY:  
 Upper gastro – intestinal endoscopy was performed with Pentax 
video endoscopy system 1998 E 3300 with nonspiked Pentax biopsy 
forceps applied with Xylocaine jelly at the tip. 
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 Endoscopic changes were noted in the Esophagus and stomach. 
Histologic study of esophageal biopsy and resected 
specimens: - 
 Two biopsy specimens were taken from the esophageal lesions 
which were immediately fixed in 10% buffered neutral formalin for 
histological evaluation. 
 
 In esophagectomy specimens the resected area was opened 
longitudinally from one end to another in the fresh state itself on the side 
opposite the tumor. The lesional area was divided into three portions as 
adjacent, proximal and distal to the tumor.  Specimens were pinned in a 
corkboard with mucosal side up, allowed to float in formalin container 
for overnight fixation. Four longitudinal sections were taken, one 
including a portion of non neoplastic mucosa proximal to tumor and 
another distal to tumor. Two sections from the cardiac end of stomach, 
one including the gastro esophageal junction was taken. Proximal 
resected margin, distal resected margin, lymph nodes if present were 
also sectioned and processed. Sections taken from biopsy and resected 
specimens that were fixed in 10% buffered formalin were processed 
routinely for paraffin embedding.  3-5µm sections were cut. The 
sections were stained with Hematoxylin and Eosin for evaluation of 
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histopathologic features, (Appendix II) Alcian blue (AB), periodic acid 
schiff stain(PAS), (Appendix I) to demonstrate metaplasia. 
 Esophageal lesions were defined and classified according to the 
established histological criteria as per Sternberg’s Diagnostic Surgical 
Pathology. 
 
 The presence of esophagitis, dysplastic changes, Barrett’s 
esophagus with intestinal metaplasia, benign and malignant neoplasm 
were recorded in all cases of esophageal biopsies. The most prevalent 
appearance in each slide was matched with the standard panel 
formulated by renowned authors, that resembles it most closely. 
  
The presence or absence of other histological features like fungal 
infections, candida, congenital abnormalties, erosions and nonspecific 
esophageal changes were also carefully looked for, paying particular 
attention to histomorphological alteration.     
 
  Histochemistry with Alcian Blue with PAS was performed to 
demonstrate the presence of goblet cells in Barrett’s esophagus. In two 
doubtful cases Immunohistochemistry with markers S100, Vimentin, 
EMA, cytokeratin was also done. 
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REVIEW OF LITERATURE 
 
 Esophagus is a hollow tube connecting the mouth and pharynx 
with the stomach; it is composed of cervical, thoracic and abdominal 
segments. It possesses no significant secretory or absorptive functions 
and its only purpose is the transport of material from the mouth to the 
stomach.  
 Esophagus is not surrounded by a serosa; this is important 
clinically since once a tumor extends beyond the muscularis propria, it 
lies within the mediastinum. 
EMBRYOLOGY: 
 Esophagus develops at about the 20th day of gestation when septa 
arising from the lateral walls of the foregut   fuse, thereby separating the 
trachea from esophagus.  
 Primitive esophagus - lined by columnar epithelium, which 
subsequently proliferates and occludes the lumen; 7th week of gestation-
esophageal lumen forms and replaced by ciliated epithelium. 
 5th month of gestation - stratified squamous epithelium appears in 
the middle third of esophagus and grows caudally and cephalad, 
replacing the cilated epithelium. 
 Esophageal mucosal glands form at 4th month of gestation. 
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 Submucosal glands do not develop until after development of 
squamous epithelium. 
ANATOMY 
  
Esophagus length varies with height of the individual, ranges 
from 25-30cm. 5,25,29,43,51  Incisor teeth to esophagogastric junction 
averages 40 cm.Resting state esophagus is collapsed and measures 3 cm 
in lateral diameter and 2 cm in anterior posterior diameter. 
UICC ESOPHAGEAL REGIONS [UICC-The International Union 
Against Cancer] 
1. Cervical region: Extends from the cricoid cartilage to the level of 
thoracic inlet. 
 2-4 Intrathoracic and abdominal regions. 
 
2. Upper thoracic segment: Extends from thoracic inlet to the 
tracheal bifurcation. 
 
3. Mid thoracic segment: Consists of the proximal half of esophagus 
between the tracheal bifurcation and the esophagogastric junction. 
 
4. Lower abdominothoracic segment: Is approximately 8 cm in 
length and is the distal half of the esophagus between the tracheal 
bifurcation and the esophagogastric junction; it includes the 
abdominal esophagus. 
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Normal Histology of Esophagus 
Fig – 1 
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The esophagogatric junction is defined as the point at which the 
tubular esophagus joins the saccular stomach.  The squamocolumnar 
junction, known as the Z-line or Ora- Serrata,5,25,29 consists  of an 
irregular serrated margin and does not necessarily coincide with 
esophagogastric junction. 
 
Squamocolumnar junction may lie anywhere within the distal 
2cm of tubular esophagus. 
Histology: 
 
 The mucosa that lines the length of the esophagus has a 
nonkeratinized stratified squamous epithelium. 
 
 The underlying lamina propria is similar to the lamina propria 
throughout the alimentary tract; diffuse lymphatic tissue is scattered 
throughout, and lymphatic nodules are present, often in proximity to 
ducts of the esophageal mucous glands.  The deep layer of the mucosa, 
the muscularis mucosae, is composed of longitudinally organized 
smooth muscle that begins near the level of the cricoid cartilage.  It is 
unusually thick in the proximal portion of the esophagus and 
presumably functions as an aid in swallowing. 
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 The submucosa consists of dense irregular connective tissue that 
contains the larger blood and lymphatic vessels, nerve fibers, and 
ganglion cells.   
 
The nerve fibers and ganglion cells make up the submucosal 
plexus (Meissner’s plexus).  Glands are also present.  In addition, 
diffuse lymphatic tissue and lymphatic nodules are present mostly in the 
upper and lower parts of the esophagus where submucosal glands are 
more prevalent. 
 
The muscularis externa consists of two muscle layers, an inner 
circular layer and an outer longitudal layer.  It differs from the 
muscularis externa found in the rest of the digestive tract in that the 
upper one third is striated muscle, a continuation of the muscle of the 
pharynx.  Striated muscle and smooth muscle bundles are mixed and 
interwoven in the musclaris externa of the middle third of the 
esophagus;  the muscularis externa of the distal third consists only of 
smooth muscle, as in the rest of the digestive tract.  A nerve plexus, the 
myenteric plexus (Auerbach’s plexus), is present between the outer and 
inner muscle layers.  As in the submucosal plexus (Meissner’s plexus), 
nerves and ganglion cells are present here.  This plexus innervates the 
muscularis externa and produces peristaltic activity. 
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The esophagus is fixed to adjoining structures throughout most of 
its length; thus its outer layer is composed of adventitia.  After entering 
the abdominal cavity, the short remainder of the tube is covered by 
serosa, the visceral peritoneum. 
 
Mucosal and submucosal glands of the esophagus secrete mucus to 
lubricate and protect the luminal wall 
 
Glands are present in the wall of the esophagus and are of two 
types.  Both secrete mucus, but their locations differ. 
y Esophageal glands proper occur in the submucosa.  These 
glands are scattered along the length of the esophagus but are 
somewhat more concentrated in the upper half.  They are 
small, compound, tubuloalveolar glands.  The excretory duct is 
composed of stratified squamous epithelium and is usually 
conspicuous when present in a section, because of its dilated 
appearance. 
y Esophageal cardiac glands are named for their similarity to 
the cardiac glands of the stomach and occur in the lamina 
propria of the mucosa.  They are present in the terminal part of 
the esophagus and frequently, though not consistently, in the 
beginning portion of the esophagus. 
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BLOODSUPPLY: 
  Arterial blood supply derives from several primary sources. 
Cervical esophagus is supplied primarily by the inferior thyroid artery; 
the upper thoracic esophagus by the bronchial and intercostal arteries; 
the lower thoracic esophagus by left gastric and inferior phrenic arteries.  
Numerous anastomoses connect the various arterial supplies. The 
venous drainages forms an extensive submucosal plexes that 
communicate with longitudinally oriented periesophageal veins and 
eventually flows into the inferior thyroid, azygous and gastric veins. In 
this manner, the caval and portal venous systems are connected, so that 
portal hypertension can result in the development of esophageal varices. 
  
Esophagus is richly endowed with lymphatic vessels that form 
free anastomosing networks within submucosa and with connecting 
longitudinal  channels in the muscularis propria.  
  
Lymphatic flow thus tends to run longitudinally coursing 
cephalad in the upper 2/3rd, and caudad in the lower 3rd of esophagus, 
which facilitates lengthwise intramural tumor dissemination  
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Cervical esophagus drains into internal jugular and paratracheal 
nodes; the thoracic esophagus into the mediastinal and bronchial nodes; 
and the abdominal esophagus into a variety of subdiaphragmatic nodes. 
Unlike the colon, these lymphatic channels traverse the esophageal wall 
into the lamina propia, thus accounting for the small but definite risk of 
lymph node metastasis with intramucosal carcinoma. 
 
REFLUX ESOPHAGITIS: 
 Casued by gastric or duodenal contents entering and injuring the 
esophagus 
 Causes: - Hiatal hernia. 
     Decreased lower esophageal sphincter pressure. 
 Endoscopy with large caliber biopsy channel and a jumbo biopsy 
forceps should be used  
Endoscopic Findings:  
 Erosions, ulceration, exudates, stricture formation.   Biopsy of 
grossly visible lesions in GERD reveals esophagitis, nonspecific   injury 
pattern.  
 
Pathological features: 
 Squamous hyperplasia25,43 – when the length of the subepthelial 
papillae of the lamina propria exceeds 2/3rd s of, and the basal zone 
occupied more than 15% of the thickness of mucosa.  
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Inflammation – includes neutrophils, eosinophil and lymphocyte. 
Neutrophils – differentiates normal from GERD, but nonspecific 
neutrophils with erosion, ulcer or associated fibrinopurulent exudates        
to exclude viral or candida infection. 
Eosinophils – significant if more than six eosinophils are present in a 
biopsy section.43 
 In children – more diagnostic of GERD. In infants more than one 
eosinophil diagnostic of GERD  
Other causes of esophageal eosinophilia :- 
Eosinophilic gastroenteritis, drug reactions- Stevens Johnson 
Syndrome, Pill induced esophagitis. 
 Recent condition – Idiopathic eosinophillic esophagitis.  
Lymphocytes: - 
 Present in large numbers in GERD No diagnostic significance 
because normal control subjects may have large numbers as well. 
 
REACTIVE HYPERPLASIA AND DYSPLASIA43: 
 The most helpful histological feature are cytoarchitectural 
uniformity in hyperplasia versus cytoarchitectural pleomorphism in 
neoplastic squamous proliferations. 
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FEATURE HYPERPLASIA DYSPLASIA 
Papillae Present, fairly, regular 
Absent or very 
irregular 
Nuclear enlargement ++ +++ 
Nuclear pleomorphism + +++ 
Nuclear overlapping + +++ 
Nuclear hyperchromasia + +++ 
Nuclear membrane Smooth May be irregular
 
 
INFECTIOUS ESOPHAGITIS 
 
Herpes esophagitis 
 
 Occurs in immunosupressed individuals. 
Endoscopy: 
 Shallow and sharply punched out, surrounded by normal 
appearing mucosa. 
 
Microscopy: Cowdry type A, dense eosionophilic intranuclear viral 
inclusion bodies, ground glass nuclei, nuclear molding, multinucleated 
giant cells, ballooning degeneration of infected cells. – in dyscohesive or 
multinucleated squamous cells. 
Cytomegalovirus esophagitis 
y Common among AIDS patients. 
y Multiple well circumscribed ulcers. 
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CMV inclusion bodies are found in endothelial cells and fibroblasts 
within granulation tissue of the esophageal ulcer base and not present in 
the surrounding squamous epithelial cells, in sharp contrast to herpetic 
inclusions43.  Presence of macrophages in a perivascular distribution, 
diagnostic clue to CMV esophagitis. 
 
Candida Esophagitis 
 Fungal esophagitis is most commonly caused by candida albicans 
and candida tropicalis.  Others are C. Krusei and C. Glabiata. 
 Because candida organisms are part of the normal flora of the GI 
tract, confirmation of this diagnosis requires pseudohyphae detection 
within the tissue more than identification of budding yeasts43. 
Endoscopy: White plaques of fibrinopurulent exudates in which 
pseudohyphae and budding yeast forms are demonstrated. 
 C.Tropicalis more virulent than C.albicans produces dysphagia 
and odynophagia. 
Other causes of small white plaques: 
1) Diffuse esophageal glycogenic acanthosis – rare manifestation of 
Cowden disease. 
- Distension of squamous epithelial cells with pale staining material 
that is PAS +ve and diastase digestible. 
2) Ectopic sebaceous glands 
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Other Causes Of Infectious Esophagitis 
y Mycobacterium tuberculosis. 
y Mycobacterium Avium intra cellulare. 
y Histoplasma capsulatum 
y Toxoplasma gondii 
y EBV 
y Idiopathic esophageal ulceration in HIV. 
Pill and drug induced esophagitis 
NSAIDS, Antibiotics – Doxycycline, Emepromium bromide, 
potassium chloride, ferrous sulfate, quinidine and alendronate 
Corrosive or caustic Esophageal injuries: 
y Alkaline. 
y Acid ingestion. 
Pathological feature are nonspecific and include tissue necrosis 
and subsequent inflammation.  
Long term complication – stricture formation. 
 
Chemoradiation induced esophagitis 
 Initially increased apoptosis within basal zone.  Bizarre epithelial 
and stromal cells.  atypical cells with low nuclear cytoplasmic ratio. 
 Vascular telangiectasia is a common feature. 
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BARRETT’S ESOPHAGUS 
 Publication by N.R.Barrett’s in 1950 first called attention to the 
columnar epithelium lined esophagus.  He described the columnar lined 
structure as intrathoracic stomach due to congenitally short esophagus.  
After the columnar lined region was demonstrated to be esophagus, 
Barrett’s proposed that the epithelium was congenital embryonic 
epithelium. 
 
 Available evidence indicates that Barrett’s esophagus is generally 
acquired as a consequence of chronic gastroesophageal reflux and reflux 
esophagitis. 
 
Evidences: 
1) Upward migration of columnar lined mucosa over time with 
continuing reflux. 
2) Development of Barrett’s mucosa with onset of gastroesophageal 
reflux after esophagogastrostomy following partial 
esophagogastrectomy. 
3) Failure to identify Barrett’s esophagus in extensive autopsy 
studies of stillborn and neonates. 
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Pathogenesis: 
 Destruction of acid, pepsin and bile sensitive squamous lined 
mucosa by chronic gastroesophageal reflux followed by re-
epithelization with more resistant columnar epithelium and which can 
undergo further metaplasia to intestinal type of differentiation.5,25,43,51  
Cell of origin51 – Migration of undifferentiated columnar 
progenitor cells from adjacent gastric and Barrett’s  mucosa, followed 
by their differentiation to columnar cells of various types. 
 Simultaneous migration of squamous progenitor cells from the 
adjacent squamous epithelium occurs, but in the abnormal milieu of 
ongoing reflux induced injury, the columnar progenitor cells may have 
selective advantage. 
 Totipotential cells differentiate into either columnar or squamous 
cells, depending upon the milieu. 
 Barrett’s mucosa can have a wide variety of topographic 
appearance. 
 Classically, Barrett’s mucosa appears as circumferential sheet 
resembling gastric mucosa without rugae that extends for variable 
distance into the esophagus about the lower esophageal sphincter. 
 Tongues, fingers or even islands of Barrett’s mucosa involving 
only portions of the esophageal circumference occur frequently. 
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1. Some portion of Barrett’s mucosa generally occurs in continuity 
with the true gastric mucosa. 
2. Islands of squamous lined mucosa often remain within the 
columnar lined region, attesting to the esophageal location. 
Variable components of Barrett’s syndrome are peptic ulcer, 
stricture, reflux esophagitis and hiatal hernia. 
A key aspect of the diagnosis of Barrett’s esophagus is 
recognition that the columnar lined esophagus may be associated with 
none, some, or all other components of morphologic Barrett’s syndrome. 
 
Histopathologic features: 
 The types of cells identified in the epithelium of Barrett’s mucosa 
include gastric type columnar mucus containing cells, which stain, with 
PAS and sometimes with alcian blue PH 2.5 (AB) and mucicarmine. 
 Columnar epithelial cells with a brush border and no mucus 
vacuoles, similar to small intestinal absorptive epithelial cells. 
 Paneth cells, with then characteristic essinophillic cytoplasmic 
granules, parietal and chief cells. 
 Neuroendocrine cells which can be argyrophil, argentaffin and 
enterochromaffin, which contains various hormones such as 
somatostatin, serotonin, substance P, enkephalin and gastrin. 
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 Macroscopic architecture of Barrett’s mucosa can include glands 
with deep and shallow pits, as in gastric mucosa and villous structures 
resembling small intestinal mucosa. 
 Lamina propria shows congestion, edema, acute and chronic 
inflammation and fibrosis. 
 Acute inflammation involving the epithelium can be 
misinterpreted as dysplasia. 
 
Histopathologic classification of Barrett’s mucosa 
 
Category 
Typical 
Macroscopic
configuration
Prominent 
glandular 
epithelial 
cells 
Predominant 
surface 
epithelial 
cells 
Evidence of 
intestinal 
differentiation
Distinctive 
type 
Villous 
structures and 
crypt like 
glands 
Columnar 
mucous 
Goblet 
interspersed 
among 
columnar 
mucous 
Goblet cells 
Absorptive 
cells, paneth 
cells (variable)
Cardiac type Glands with deep pits 
Columnar 
mucous 
Columnar 
mucous Absent 
Fundic type Islands with shallow pits 
Parietal, 
chief cells 
Columnar 
mucous Absent 
Indeterminate 
type Variable Variable Variable Variable 
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Distinctive type Barrett’s mucosa:51 
 
 Has villiform configuration and crypt like glands. 
 
 Glands are often continuous with muscularis mucosa and no 
intervening connective tissue is present. 
 
 It indicates previous ulceration of the lamina propria with 
epithelial regeneration directly on the smooth muscle. 
 
 Goblet cells that stain PAS, AB & Mucicarmine are both 
interspersed and contiguous with columnar mucous cells. 
 
 Which is identical to that of incomplete intestinal metaplasia of 
gastric mucosa but contrasts with that of complete intestinal metasplasia 
in which columnar cells are inapparent in intestinalised glands. 
 
 Distinctive type Barrett’s mucosa is present in majority of adult 
patients with Barrett’s esophagus but found less frequently in children, 
providing evidence for the occurrence of intestinalisation overtime. 
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Cardiac type Barrett’s mucosa:51 
y Resembles gastric cardiac mucosa. 
y Contains deep pits which produce, villiform configuration. 
y Mucus containing epithelial cells are more predominant in both 
surface and glandular epithelium Goblet cells are scarce. 
Features of cardiac type Barrett’s mucosa that differ from those of 
normal gastric mucosa include glandular distortion, edema and chronic 
inflammation. 
 
Fundic type Barrett’s mucosa:51 
y Least common 
y Shallow pits lined by mucus containing columnar cells and a 
heavy component of parietal and chief cells in the glands.  
Intestinal differentiation is absent. 
y Mosaic distribution of various types of mucosa seen. 
Indeterminate type Barrett’s mucosa:51 
 Wide spectrum of histopathologic features. 
 Presence of dysplasia can lead to classifications as indeterminate 
type obscuring the characteristics of antecedent columnar epithelium. 
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Type and origin of Epithelial tumors of Esophagus:51 
 
 
TUMOR TYPE ORIGIN 
MALIGNANT TUMORS: 
      Squamous cell carcinoma 
            Ordinary squamous cell  
            carcinoma 
            Verrucous carcinoma 
            Basaloid carcinoma 
            Spindle cell carcinoma 
 
 
 
Squamous epithelium 
Squamous epithelium 
Squamous epithelium 
Squamous epithelium 
ADENOCARCINOMA 
            Ordinary adenocarcinoma 
            Adenoacanthoma 
            Mucoepidermoid carcinoma 
            Adenoid cystic carcinoma 
            Choriocarcinoma 
 
Columnar epithelium 
Columnar cell with metaplasia 
Esophageal gland duct 
Esophageal gland duct 
Germ cell rest 
COMPOSITE TUMORS 
             Adenosquamous carcinoma 
   
             Carcinosarcoma 
             Small cell carcinoma and  
             carcinoid 
             Malignant melanoma 
 
Squamous cell with metaplasia or 
esophageal gland duct 
Totipotential or mixed stem cells 
 
Foregut endocrine cell 
Melanocytes 
Benign Tumors: 
             Squamous cell papilloma 
             Adenoma 
 
Squamous epithelium 
Columnar epithelium or duct 
 
PATHOLOGY OF SQUAMOUS CELL CARCINOMA: 
 The most common site of squamous cell carcinoma of the 
esophagus is the middle one third followed by lower and upper thirds. 
 The anatomic structures surrounding the esophagus are different 
at different levels. 
 Location of the tumors therefore is a major factor in determining 
the surgical management of esophageal SCC. 
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EARLY SQUAMOUS CELL CARCINOMA:51 
 Defined as a tumor that has not extended beyond the submucosa 
and has not metastasized. 
 Improved survival of patients. 
Gross appearance  
1. Plaque type – commonest  
2. Erosive 
3. Papillary 
4. Occult type. 
Plaque type has platform like structure, granular and white 
surface. 
HPE: 
 45% - intramucosal 
 33% - submucosal 
 remainder – intraepithelial 
Erosive type - depressed and eroded 
 Most are intra epithelial or intra mucosal. 
Papillary type – elevated and eroded with polypoid or papillary 
contours. 
Occult type – small, displays pink or congested surface, flat, difficult to 
recognize grossly.  All are intraepithelial. 
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Histologically Three types: 
1. Intraepithelial  
2. Intramucosal 
3. Submucosal 
Intraepithelial carcinoma: 
 Malignant squamous cells involving the entire thickness of the 
squamous epithelium underlined by an intact basement membrane, 
hence squamous cell carcinoma in situ. 
Intraepithelial spread of squamous cell carcinoma: 
 Spreading malignant cells and the apposing non neoplastic 
epithelium create a sharp demarcation. 
Intramucosal type of early carcinoma:  
 Infiltration of malignant cells in the lamina propria but not 
beyond. Epithelium stroma interface shows an irregular borde. 
Submucosal squamous cell carcinoma: 
 Malignant cells have penetrated the muscularis mucosa into the 
submucosa but have not reached the muscularis propria. It shows 
frequent lymphnode metastases and lower survival rates than 
intraepithelial and intramucosal squamous cell carcinoma.51 
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Advanced squamous cell carcinoma: 
 
      Fungating – most common form25,43,51 
Gross       
    Ulcerative 
 
    Infiltrating  
 
Chinese Classification:51 
 Medullary  
 Fungating 
 Ulcerative 
 Scirrhous 
 Intraluminal (polypoid) 
 
Microscopical Classification: 
 Well differentiated  
 Moderately differentiated 
 Poorly differentiated 
Well differentiated SCC: 
 Oval or polygonal tumour cells with oval or round nuclei and 
prominend nucleoli.  Tumour cells exhibit some degree of maturation.  
Keratin pearls - Keratin production in the center of tumour cell groups 
surrounded by flattened keratotic cells with pyknotic nuclei. Mitoses are 
uncommon. 
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Moderately differentiated SCC: 
  Cells are slightly smaller, more pleomorphic than well 
differentiated SCC. Mitoses are easily found. Focally, keratin can be 
observed. Tumor cells form sheets, cluster and ribbon like arrangement. 
 
Poorly differentiated SCC: 
 Extremely pleomorphic cells. 
Round, polygonal to spindly. 
 Tumors necrosis and mitoses are common. 
Grades: 
 Grade I  – Well differentiated SCC 
 Grade II  – Moderately differentiated SCC 
 Grade III  –  Poorly differentiated  SCC 
Multiple squamous cell carcinomas51: 
 Second lesions tend to arise proximal to the primary SCC of the 
lower esophagus and distal to the upper SCC. 
Criteria 
a) The primary lesions shows malignant features. 
b) The second carcinoma shows in situ changes. 
c) At least 1.5 cm of healthy esphogeal tissue exists between 
these two lesions. 
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High prevalence of multiple esophageal SCC in alcoholics with 
mutant aldehyde dehydrogenase 2*2 allele.51 
Mutated ALDH 2*2 Æ enzyme inactivity. 
Blood level of aldehyde increases after drinking.  
Multiple epithelial cells of the esophagus are aldehyde 
preconditioned, which may be activated with exposure to known 
carcinogens. (smoking etc) 
Æ Irreversible malignant change. 
P53 alteration - key event in multifocal esophageal 
carcinogenesis. 
 
Variants of squamous cell carcinoma 
 
Verrucous carcinoma 
 Rare, distinct type 
 
Gross: exophytic, cauliflower like or papillary and white. 
 
Microscopy: superficial part of the tumor shows characteristic 
papillary projections, but the deeper part is composed of acanthotic 
squamous epithelium, compressing or infiltrating the underlying tissue. 
 Malignant cells are characteristically found in the basal layers. 
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Basaloid carcinoma: 
 Characterized microscopically by solid sheets or island of tumor 
cells surrounded by basal lamina, closely resembling features of basal 
cell carcinoma of the skin, or by gland like structures resembling, those 
of salivary gland. 
 
 The tumor cells are small, have relatively scanty cytoplasm, 
similar to the basal cells of squamous epithelium. 
 
 Peripheral palisading is prominent and characteristic of basaloid 
carcinoma with frequent mitoses and focal necrosis. 
 
Spindle cell carcinoma and carcinosarcomas 
 
Gross: polypoid 
  
 Tumors may reach a diameter of 15cms.  No sharp demarcation 
between malignant spindle cell and squamous cell carcinoma 
components. 
 Osseous, cartilage and muscular tissue may be seen. 
 Results of light and electron microscopic and immuno 
histochemical studies demonstrate that these tumors are heterogeneous 
but can be categorised into 2 groups51. 
Carcinosarcoma: – epithelial nature of SCC and mesechymal nature 
of malignant spindle cell components are proven 
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Sarcomatoid carcinoma: - 
 Tumour in which both SCC and malignant spindle cells show 
epithelial markers. 
Composite carcinomas: 
 Synonym- chimeric tumor.  Some esophageal cancer show two or 
more cellular components. 
 Different components either intermingle or demonstrate transition 
from one to another. 
(e.g.) Adenosquamous carcinoma 
         SCC with small cell carcinoma 
         SCC with carcinoid 
 
Cell of origin of Adenocarcinoma51  
Columnar epithelium of esophagus.   
Congenital remnants and gastric heterotopia: 
 Incidence 11.8% in children and 4 to 10% in adults.  These 
patches consists of fundic type of gastric glands with chief and parietal 
cells and measures 0.2 to 0.3 cm. 
Barrett’s epithelium: 
 Is pink and velvety, resembling gastric mucosa in contrast to the 
light gray normal squamous mucosa. 
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Congenital or ectopic gastric epithelium can be readily 
differentiated from the Barrett’s epithelium by well formed fundic 
glands whereas Barrett’s epithelium shows intestinal metaplasia. 
 
Submucosal esophagal glands: 
 Submucosal glands with ducts penetrating through the squamous 
epithelium into the lumen of esophagus. 
Uncommon cell types of Esophageal epithelium: 
 Normal esophageal squamous epithelium has scattered endocrine 
and melanocytes. 
 Endocrine cells are argyrophilic-giving rise to carcinoid and small 
cell carcinoma. 
 Melanocytes give rise to rare melanomas. 
 
Dyplasia of Barrett’s epithelium: 
  Mild 
 Moderate 
Severe 
 
Low grade 
High grade includes both moderate and severe dysplasia, 
also includes in situ carcinoma 
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 Low grade mild dysplasia shows decreased mucous secretion, 
crowding of slender columnar cells with pseudostratified nuclei and 
occasional nuclear pleomorphism, mitosis absent. 
 High grade dysplasia shows moderate pleomorphism, plump cells 
marked reduction of mucus secretion and frequent mitosis.  Glands may 
show budding, branching, crowding and intraluminal folding. 
 
ADENOMA: 
 Consists of dysplastic epithelium, localized growth, sharp 
demarcation with surrounding tissue. 
 
ADENOCARCINOMA: 
  Flat, some may be polypoid and larger 4.5cm. 
  Most advanced tumors all flat and ulcerated 25,43,51. 
 1/3rd are polypoid or fungating. 
 Diffuse infiltrative lesions in the form of linitis plastica and gross 
papillary lesions are rare. 
 
Microscopic features: 
 Majority are well or moderately differentiated tubular 
adenocarcinoma. 
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Microscopic classification 
 Well differentiated. 
 Moderately differentiated. 
 Poorly differentiated 
 Mucinous. 
 Signet ring cell type. 
 Lauren’s classification used for gastric carcinoma can be used for 
adenocarcinoma of esophagus too. 
Adenocarcinoma at the esophagogastric junction: 
 Majority are adenocarcinomas  
2/3rd of adenocarcinomas arise from stomach. 
 1/3rd from esophagus. 
 Basis for differentiation is location of the center of the tumor and 
presence of specific structures of the respective organs25, 43,51. 
 Esophagus – specialized, incompletely intestinalised epithelium 
gives a clue. 
Adenoacanthoma and adenosquamous carcinoma 
 Adenoacanthoma is adenocarcinoma with focal squamous 
metaplasia, rare 
 Adenosquamous carcinoma is basically a squamous cell 
carcinoma with occasional mucus secreting glandular components. 
 Same outcome as that for tumors without the minor metaplastic 
components. 
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Mucoepidermoid carcinoma:  
 Arises from esophagal gland ducts.  Composed of both squamous 
and glandular cells. 
 50% occur in the middle one third esophagus.  Aggressive, 
extensive invasion and lymph node metastasis are common. 
 
Adenoid cystic carcinoma: 
 Origin from the intercalated duct of submucosal esophageal 
glands. 
 Mostly in middle 3rd of esophagus in the submucosa51. 
 Histologically, lesions are composed of well defined islands of 
tumor cells with a cribriform pattern and many cystic spaces. 
 
Carcinoid: 
 Submucosal tumors, arise mostly in the distal esophagus, 
composed of uniform polygonal or round cells in sheets and trabeculae, 
with salt and pepper type chromatin containing nuclei. 
 
Small cell carcinoma: 
 Arises in the middle and distal segment, second to the lung, 
esophagus is the most common site for small cell carcinoma25,51. 
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Gross: 
 Large, fungating or ulcerated, polypoid form is rare. 
 Histologically, tumor is composed of small cells with 
hyperchromatic nuclei and scanty cytoplasm. 
 Poor prognosis. 
 
 
Malignant melanoma: 
 Rare, about 10% of esophageal malignant tumors, frequently in 
lower esophagus. 
 Tumor is characterized by marked cellularity, frequent mitosis, 
presence of intra cellular as well as extracellular melanin pigments. 
 Junctional changes with melanoma cells at the base of the 
covering squamous epithelium are common. 
Choriocarcinoma: 
 Large ulcerated tumors mainly lower segment, rare tumors 
composed of cyto trophoblast and syncytiotrophoblasts. 
 
Paget’s disease: 
 Large clear pagetoid cells found in the squamous epithelium and 
glandular ducts without stromal invasion.  
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SECONDARY AND METASTATIC TUMORS: 
 3% of all carcinoma show metastases to esophagus. 
 
Direct spread: From lung or mediastinal lymph nodes.Carcinoma of the 
upper stomach and hypopharynx may extend into the contiguous 
esophagus or metastasized to esophageal wall by lymphatics.Metastatic 
tumors are submucosal, small and asymptomatic.Exception is metastic 
melanoma, forms  large pigmented polypoid mass51. 
 
BENIGN TUMORS AND TUMOR LIKE LESIONS 
 Benign tumor are mostly mesenchymal benign epithelial       
tumors 25, 51, squamous cell papilloma and adenoma are rare. 
Squamous papilloma 
 Sessile lesions.  Its papillae are composed of a central core of 
connective tissue covered with hyperplastic squamous cells in an orderly 
arrangement and without dysplastic changes. Distal esophagus is the 
usual site. 
 
Cysts: 
 Retention cysts formed by dilated ducts of esophageal glands are 
common. Submucosal, more in lower segment. Duplication cysts of 
developmental origin are primarily extramural and connect with the 
esophagus only partially if at all. Cysts may be lined by esophageal, 
bronchial or gastric epithelium. 
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Leiomyoma: 
 Although it is the most common benign tumor of the esophagus, 
leiomyoma seldom poses a clinical problem. In general these tumors 
appear as circumscribed  mural masses, usually solitary, and  2 to 5 cm 
in diameter, that bulge into the lumen and may even form pedunculated 
polyps. Minute “seeding” leiomyomas of 1- to 2-mm diameter can be 
commonly identified in the vicinity of the gastroesophageal junction.  
The morphologic features mirror those of other classic 
leiomyomas: interlacing fascicles of bland spindle cells with variables 
fibrosis produce the traditional circumscribed, white-gray whorled 
appearance on gross examination. Distinction from the very rare 
esophageal leiomyosarcoma and esophageal gastrointestinal stromal 
tumor is not difficult based upon morphologic and immunophenotypic 
findings. 
 
Mesenchymal polyps:  
 
 A polypoid configuration is the most memorable feature of 
several benign esophageal lesions of unsettled pathogenesis. 
Fibrovascular polyps are characterized by a core of mature fibrous 
tissue, occasionally myxoid, with scattered thin walled vessels and a 
variable admixture of adipose tissue. The overlying mucosa is generally 
intact, but may be secondarily eroded.  
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The histologic variety explains this polyp’s numerous synonyms, 
which include fibroma, fibrolipoma, fibromyxoma, and lipoma. 
Typically these polyps arsie in the upper esophagus from the 
cricopharynegeal region, and they present as elongated pedunculated 
masses that may range up to 20 cm in length.  
 Inflammatory fibroid polyps similar to those found else-where in 
the gastrointestinal tract have also been described in the esophagus. 
They comprise a submucosal proliferation of reactive fibroblasts and 
small vessels bestrewn with inflammatory fibroid polyps are located in 
the mid or   lower esophagus and harbor a more diffuse inflammatory 
component, although the distinction between the two without great 
clinical importance. 
 Inflammatory esophagogastric polyps are composed of 
granulation tissue and edematous lamina propria with inflammation. 
They occur near the gastroesophageal junction and probably result from 
reflux –associated ulceration and repair.  
Granular Cell Tumor: 
 The esophagus is one of the favored gastrointestinal sites for 
granular cell tumors25. Most are solitary, asymptomatic lesions that arise 
in the distal esophagus. However, in some cases, multiple lesions arise 
in the same patient, either limited to the esophagus or distributed in 
multiple gastrointestinal tract sites. Grossly, they appear as intramural 
nodules, poorly circumscribed, and generally less than 2 cm in diameter.  
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They resemble granular cell tumors from other sites and are 
composed of sheets of uniform cells with small nuclei and abundant 
granular PAS – positive cytoplasm that exhibits S100 protein 
immunoreactivity. The overlying squamous epithelium can undergo 
pseudoepitheliomatous hyperplasia that may be so profound as to be 
mistaken for squamous cell carcinoma. Most esophageal granular cell 
tumors are stable or slowly growing benign lesions, but rare examples 
with malignant behavior have been reported. 
 
Miscellaneous: 
 Case reports describe all types of benign soft tissue tumours 
occurring in the esophagus: hemangiomas, lymphangiomas, glomus 
tumors, osteochondromas, and neurofibromas. Hamartomas fashioned 
from a mixture of fibrous, muscular, cartilaginous, and glandular tissues 
are found in infants. 
 
Endoscopic picture29 
 
 Esophago gastric junction mucosa: also known as dentate or Z 
line.Columnar line segment is orange red to red, and is distinctly 
different from the pinkish, gray colour of normal esophageal squamous 
mucosa.  The dentate line is sometimes regular, giving the appearance of 
sharp ring like demarcation. (Fig 3) 
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Fig 3 Endoscopic appearance of Gastroesophageal  junction –red columnar mucosa  
          with pink squamous mucosa –dentate or Z line. 
 
 
 
 
 
 
 
 
 
 
Fig 4 Endoscopic appearance of Barrett’s mucosa –irregular tongues of red  
          glandular mucosa extending up into the pink squamous mucosa. 
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Fig 5 Endoscopic appearance of Carcinoma esophagus-irregular obstructive growth  
          with menisci sign. 
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Barrett’s esophagus 
 The squamo columnar junction is irregular.  Tongues of red 
columnar mucosa extends into pink squamous mucosa. (Fig 4)  The 
extend is recorded in centimeters from the columnar junction to the 
point at which the lumen changes from a tubular shape into a cavity. 
Carcinoma of the esophagus 
 Irregular, relatively firm, ulcerated surface.  Some times polypoid, 
obstructive with menisci sign29. (Fig 5) 
CHROMOENDOSCOPY 
Chromoendoscopy42 
 Chromoendoscopy uses chemical staining agents applied to the 
gastrointestinal (GI) mucosa to identify specific subtypes of epithelia or 
to highlight surface characteristics of the epithelium.  Chromoendoscopy 
has been used in several regions of the GI tract, including the esophagus, 
stomach, duodenum, and colon, to aid the characterization of multiple 
disease states. 
 Two types of tissue staining are used in the esophagus.  Vital, or 
absorptive stains, such as Lugol’s solution, methylene blue, and 
toluidine blue are all actively taken up by esophageal mucosa, Contrast 
stains are not absorbed but highlight the surface of the mucosa, allowing 
for the identification of minute lesions and subtle patterns.  Contrast 
stains currently used in the esophagus include indigo carmine and dilute 
acetic acid solution. 
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Lugol’s solution 
 Lugol’s solution is an inexpensive, widely available solution 
comprising a mixture of iodine and potassium iodide.  This vital stain is 
absorbed by glycogen-containing, nonkeratinized, squamous epithelium, 
the normal tissue type in the esophagus.  Lugol’s-stained tissue 
characteristically turns green-brown.  The intensity is partly dependent 
on the amount of glycogen present within the epithelium.  Inflammatory 
or dysplastic squamous epithelium, squamous cell carcinoma, and 
columnar epithelium do not stain with Lugol’s solution.  This stain is 
used as a 1% or 2% solution in a volume of 20 to 50 ml sprayed through 
endoscopic catheters. 
Toluidine blue 
 Toluidine blue is a basic metachromatic vital stain that has been 
used in the evaluation of oral and female genital tract lesions and 
squamous cell carcinoma of the esophagus.  This stain is also useful in 
the endoscopic detection of BE, IM was detected with 98% sensitivity 
and 80% specificity. 
Methylene blue 
 Metaplastic epithelum, including IM of the stomach and 
esophagus, also absorbs methylene blue. 
 Methylene blue is not absorbed by normal squamous or gastric 
epithelium. 
 Before applying the stain, surface mucous must be removed to 
expose as much surface area as possible for staining. 
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ENDOSCOPIC BRUSH CYTOLOGY 
 
Cytology in Barrett’s esophagus42 
 
Limitations of current endoscopic biopsy surveillance 
programs 
 Current guidelines suggest obtaining systematic four-quadrant 
biopsy specimens at 2-cm intervals along the entire length of the 
Barrett’s segment once inflammation related to gastroesophageal reflux 
disease is controlled with antisecretory therapy. 
Potential advantages of endoscopic brush cytology 
 The sensitivity of combined endoscopic biopsy and cytology is 
92% to 100% for the diagnosis of gastroesophageal malignancy, which 
is better than biopsy or cytology alone. 
 
Technique and processing of brush cytology 
 Endoscopically directed brush cytology samples should be 
obtained before biopsy.  Cytologic samples are obtained with a cytology 
brush from all four quadrants along the entire length of the Barrett’s 
segment and from any endoscopically noted abnormalities, such as 
ulcers, erosions, nodules, or plaques. 
 Cytologic specimens may be prepared as either conventional 
smears or with liquid-based techniques such as ThinPrep (Cytyc, 
Marlborugh, MA).  The ThinPrep process involves specimen collection 
directly into a methanol-based preservative solution.   
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This solution is centrifuged, and after discarding the supernatant, 
the cell pellet is resuspended and a sample transferred to a second 
methanol-based preservative.  An automated device, the ThinPrep 
Processor subsequently prepares cytology slides with a thin layer of 
evenly dispersed cells. 
 
Cytologic criteria in Barrett’s esophagus 
 Cytologic specimens may be categorized as satisfactory or 
unsatisfactory by the presence or absence of well-visualized cellular 
elements.  Satisfactory specimens can then be further classified into one 
of the three categories.  Specialized columnar epithelium present, 
diagnostic of BE; columnar epithelium present, consistent with BE; or 
no evidence of Barrett’s epithelium.  Specialized columnar epithelium 
may be defined as the presence of goblet cells, identified by large well-
delineated cytoplasmic vacuoles.  The cellularity of specimens 
containing columnar cells may be subjectively evaluated as mildly, 
moderately, or markedly cellular. 
 Specimens with columnar epithelium may be classified into one 
of four categories: negative of dysplasia, indefinite for dysplasia, High 
Grade Dysplasia (HGD) and adenocarcinoma. 
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Barrett’s epithelium negative for dysplasia typically occurs in 
large cohesive cellular sheets, the edges of which are sharply defined 
and smooth.  Cellular polarity is maintained with nuclei uniformly 
distributed within the groups, creating a honeycomb appearance.  The 
benign nuclei, containing finely granular chromatin, have an oval 
configuration with smooth external nuclear contours and vary little in 
size.  When goblet cell differentiation is present, it usually is obvious as 
large well-delineated cytoplasmic vacuoles. 
 
 Nuclei are variably enlarged with aberrations of the nuclear 
membrane, such a thickening, notches, and irregular contours.  Nucleoli 
are more prominent and the nuclear-cytoplasmic ratio is enlarged 
compared with non-dysplastic cells.  Cell groups are smaller and more 
heterogeneous, frequently forming three-dimensional aggregates.  A 
major difference between cytologic samples negative for dysplasia and 
dysplasia-adenocarcinoma specimens is the arrangement of the 
constituent cells. 
 
 Cells are variable in size and shape and there is a strikingly 
irregular and haphazard distribution of cells within the aggregates with 
irregular crowding and nuclear overlap.   
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Another prominent feature of dysplasia-adenocarcinoma is loss of 
intercellular cohesiveness manifested as frayed edges to the cellular 
groupings, with cells at the margins of aggregates appearing to fall 
away.  Large numbers of atypical aggregates and single atypical cells 
and giant nuclei are considered more characteristic of adenocarcinoma 
than dysplasia.  
  
The term “indefinite of dysplasia” is used for preparations with 
atypical cellular features that are not sufficiently developed to permit an 
unequivocal interpretation of HGD or adenocarcinoma or frank 
adenocarcinoma. 
Efficacy data 
 Despite its successful use in other cancer programs, surprisingly 
little information is available on the usefulness of cytology in the 
diagnosis and surveillance of BE.  The potential for endoscopic brush 
cytology was first described by Belladonna et al in a 1974 cases report 
of a patient with an esophageal stricture on barium radiography that 
could not be confirmed at endoscopy.  Biopsy specimens obtained from 
an area of inflammation revealed columnar epithelium but no neoplasia.  
Endoscopic brushings and washings both demonstrated 
adenocarcinoma, however.  Esophageal resection revealed multi-focal 
adenocarcinoma. 
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 Compared with histologic analysis, the sensitivity of cytology for 
detecting specialized columnar epithelium was 82% and the specificity 
was 100%.  Furthermore, Barrett’s epithelium of the specialized type 
was detected only by cytology and not by histology in 11 patients. 
 
Nonendoscopic techniques42 
 
 Given the high cost of endoscopic surveillance and the potential 
benefits and lower cost of cytology, blind, nonendoscopically directed 
balloon cytologic sampling has been suggested as a potential cost-
effective alternative for cancer surveillance in patients with BE. 
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OBSERVATION AND RESULTS 
 
 This study covered a total of 323 cases in which 277 were 
endoscopic biopsies and 46 were esophagectomy specimens. 
 In 277 endoscopic biopsies 193 were males (69.68%) with age 
ranging from 20 to 80 yrs (mean age 50 yrs),  84 were females (30.33%) 
with age ranging from 20 to 80 yrs (mean age 50 yrs). 
 The clinical presentation, endoscopic picture, and 
histopathological features, are listed in the master chart. 
 Table No1 shows the total number of esophageal biopsy 
specimens referred for histopathological evaluation during the period 
January 2000-September 2005. The average incidence is 9.75%.   
TABLE I 
 
S. 
No Period 
Total no of 
Biopsies 
Esophageal 
Biopsies Percentage
1 Jan2000-Dec2000 410 49 11.95% 
2 Jan2001-Dec2001 510 59 11.56% 
3 Jan2002-Dec2002 613 56 9.13% 
4 Jan2003-Dec2003 523 52 9.94% 
5 Jan2004-Dec2004 469 37 7.88% 
6 Jan2005-Sept2005 300 24 8.0% 
Average 9.75% 
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Table No I A shows the incidence of esophageal specimens 
received after initial endoscopic evaluation for management during the 
period from 2000 to 2005. 
The average incidence is 0.30% 
Table I A 
S. 
No Period 
Total no of 
specimens 
Esophageal 
Specimens Percentage
1 Jan 2000-Dec 2000 2124 4 0.188% 
2 Jan- Dec 2001 2306 6 0.260% 
3 Jan-Dec 2002 2609 6 0.229% 
4 Jan-Dec 2003 2344 11 0.469% 
5 Jan- Dec 2004 2795 16 0.572% 
6 Jan-Sep 2005 2280 3 0.131% 
Average 0.308% 
 
 
AGE INCIDENCE: 
The patients clinically manifested with dysphagia, weightloss, 
nausea and vomiting who were further biopsied were divided into           
6 groups according to their age [i.e. 20-30yrs, 31-40yrs, 41-50yrs,         
51-60yrs, 61-70yrs, 71-80yrs.] 
There was increased incidence of esophageal lesion observed in 
the age group of 51-60 yrs (33.21%) followed by 41-50 yrs (24.55%) 
and  61-70yrs (14.49%). 
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The age distribution of esophageal biopsies is given in            
Table No II  
Similarly the age distribution of esophageal specimens received 
were also calculated accordingly as given in Table II A. 
                        
Table II 
 
No. of Cases S. 
No Age Group M F T 
Percentage
1 20-30yrs 9 6 15 5.415% 
2 31-40yrs 19 18 37 13.357% 
3 41-50 yrs 42 26 68 24.548% 
4 51-60yrs 73 19 92 33.2129% 
5 61-70 yrs 43 11 54 19.495% 
6 71-80yrs 7 4 11 3.97% 
 
 
Table II A 
 
No. of Cases S. 
No Age Group M F T 
Percentage
1 20-30 1 0 1 2.173% 
2 31-40 0 3 3 6.521% 
3 41-50 6 6 12 26.086% 
4 51-60 14 5 19 41.304% 
5 61-70 8 2 10 21.739% 
6 71-80 1 0 1 2.173% 
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Most of the patients belong to lower socio economic status, lived 
in overcrowded surroundings 
 
Table No III shows the distribution of cases according to their 
clinical presentation in endoscopic biopsies. 
 
Table No III 
 
 
S. 
No Features 
Number of 
Cases Percentage 
1 Dyspepsia 69 24.91% 
2 Dysphagia 250 90.25% 
3 Loss of weight 194 70.04% 
4 Anorexia 152 54.87% 
5 Vomiting 69 24.91% 
6 Odynophagia 78 28.16% 
7 Regurgitation of food 90 32.49% 
8 Hoarseness of voice 2 0.72% 
9 Heart burn 52 18.77% 
 
 
Most of the patients in our study had complained of dysphagia 
(90.25%)  followed by  loss of weight (70.04%) and anorexia (54.87%) . 
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DISTRIBUTION OF CASES IN 
ENDOSCOPIC BIOPSY
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ESOPHAGEAL BIOPSY EVALUATION 
277 cases of esophageal biopsy were received and 
histopathological evaluation was done. 
Among the 277 cases, 9 cases were Barrett’s (Fig 6) (3.249%), 18 
cases were diagnosed as adenocarcinoma (Fig 7 & 8) (6.498%) 176 
cases were diagnosed as squamous cell carcinomas (Fig 9) (63.18%) 42 
cases were squamous intraepithelial lesion (Fig 10) (15.16%) 14 cases 
were interpreted as normal stratified squamous epithelium (5.05%) 14 
cases were interpreted as only necrotic material /no tissue (5.05%). 
Table No IV  shows the incidence of lesions and its percentage. 
Table No IV 
 
 
S. 
No Type of lesions Male Female Total Percentage
NON NEOPLASTIC LESION 
Normal 
 
11 
 
3 
 
14 
 
5.05% 1 
No tissue 11 3 14 5.05% 
2 BARRETT’S ESOPHAGUS 7 2 9 3.25% 
NEOPLASTIC –BENIGN 
Squamous Papilloma 
 
1 
 
0 
 
1 
 
0.36% 3 
Fibromuscular Polyp 1 0 1 0.36% 
4 PRENEOPLASTIC  SIL 
 
27 
 
15 
 
42 
 
15.16% 
MALIGNANT NEOPLASM 
Squamous cell carcinoma-
Usual Type 
 
 
115 
 
 
60 
 
 
175 
 
 
63.18% 
Sarcomatoid Carcinoma 1 0 1 0.36% 
Adenocarcinoma 16 2 18 6.49% 
Adenosquamous Carcinoma 1 0 1 0.36% 
5 
Malignant Melanoma 0 1 1 0.36% 
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Fig 6 Barrett’s esophagus –intestinal metaplasia with goblet cells between mucous  
          producing cells (H & E X100). 
 
 
 
 
 
 
 
 
 
 
Fig 6A Barrett’s esophagus –columnar epithelium with goblet cells (H & E X400). 
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Fig 7 Adenocarcinoma arising from Barrett’s esophagus –glandular and tubular  
         profiles, lined by columnar cells. Biopsy (H & E X100). 
 
 
 
 
 
 
 
 
 
Fig 7A Squamous epithelium continuous with neoplastic glandular epithelium high  
            power view of above X400↑. 
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Fig 8 Mucoid carcinoma –abundant mucin pool with signet ring cells. Biopsy   
          (H & E X100). 
 
 
 
 
 
 
 
 
 
Fig 8A Mucoid carcinoma clusters of neoplastic cells against pool of mucin. Biopsy   
            (H & E X400). 
 
 
 67
 
 
 
 
 
 
 
 
 
 
Fig 9 Well differentiated squamous cell carcinoma – Keratin pearl formation.Biopsy  
          (H & E X 100). 
 
 
 
 
 
 
 
 
 
Fig 9A High power view of above X 400↑. 
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Fig 10 Low grade squamous Intraepithelial lesion dysplastic changes confined to the  
            lower one third of mucosa. Biopsy (H & E X 100). 
 
 
 
 
 
 
 
 
 
 
Fig 10A High power view of above X400↑. 
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Table no IV shows Squamous cell carcinoma (SCC) of the 
esophagus is the commonest  malignant neoplasm  [176 cases, 
(63.54%)] followed by SIL [42 cases, (15.16%)]. Incidence of 
Adenocarcinoma esophagus is only 6.49% Table IV.A and Table IV B 
shows, in esophageal biopsies Squamous cell carcinoma was the 
commonest neoplasm (males 41.87%, Females 21.66%) followed by 
squamous intra epithelial lesion (Males 9.75%, Females 5.42%)  
Incidence of Barrett’s esophagus characterised by metaplastic columnar 
epithelium intestinal type with goblet cells that has replaced the original 
squamous lined mucosa is also observed. In males 7 cases of BE 
(2.53%) was observed and 16 cases of Adenocarcinoma (5.78%) was 
seen. Table IV A and B also clearly shows the esophageal lesion 
(Neoplastic, pre neoplastic) are common in males when compared with 
females and the incidence of Adenocarcinoma is much low when 
compared with classical SCC. 
Table IV A 
Male Incidence 
S. 
No Type of Lesion No. of Cases Percentage 
1 Barrett’s esophagus 7 2.527% 
2 SIL 27 9.75% 
3 SCC 116 41.877% 
4 Adenocarcinoma 16 5.776% 
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Fig 11 Squamous papilloma –stratified squamous epithelium with central  
            fibrovascular core. Biopsy (H & E X100). 
 
 
 
 
 
 
 
 
 
Fig 12 Fibrovascular polyp – intact surface epithelium with loose connective tissue  
            in lamina propria. Biopsy (H & E X 100). 
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Fig 13 Adenosquamous carcinoma –mixed squamous and glandular differentiation  
           of neoplastic cells. Biopsy (H & E X100). 
 
 
 
 
 
 
 
 
 
Fig 13A High power view of above X400 –with glandular component. ↑. 
 
 
 72
 
 
 
 
 
 
 
 
 
Fig 14 Malignant melanoma –basal proliferation of melanocytes and invasive   
           epitheloid component. Biopsy (H & E X100). 
 
 
 
 
 
 
 
 
Fig 14A Malignant melanoma with obvious intra cytoplasmic pigmentation.  
               (H & E X400). 
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Fig 15 Sarcomatoid carcinoma –Epitheloid malignant squamous cells blend  
           imperceptibly with an undifferentiated sarcomatous component. Biopsy   
          (H & E X100). 
 
 
 
 
 
 
 
 
 
 
Fig 15A High power view of above X400 –proliferation of spindle cells with   
              hyperchromatic elongated nuclei. ↑. 
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Table IV B 
Female Incidence 
 
S. 
No Type of Lesion No. of Cases Percentage 
1 Barrett’s esophagus 2 0.72% 
2 SIL 15 5.415% 
3 SCC 60 21.66% 
4 Adenocarcinoma 2 0.722% 
 
Among the 277 cases one case of Squamous Papilloma (Fig 11) 
which occurred in a 50 yrs male with characteristic features of central 
core of connective tissue covered with hyperplastic  Squamous cells in 
an orderly arrangement and without dysplastic changes was observed. 
One case of fibromuscular polyp (Fig 12) composed of mesenchymal 
tissue which was fibrous and covered by intact Squamous epithelium 
occurred in 38 yrs males. One case of adenosquamous carcinoma        
(Fig 13)  characterised by proliferation of malignant glands adjacent to 
malignant squamous epithelium was observed in 70 yrs male. One case 
of malignant melanoma (Fig 14) characterised by small dark, flat lesion 
in the upper GI endoscopy which revealed aggregates of pleomorphic 
cells with hyperchromatic nuclei, binucleated cells and intracellular 
melanin pigmentation, was observed in 60 yrs female. One case of 
sarcomatoid carcinoma (Fig 15) with features of both spindle cells and 
squamous cell carcinoma components was observed in 55 yrs male. 
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HISTOPATHOLOGICAL EVALUATION: 
 46 esophagectomy specimens were received, of which 41 cases 
(89.13%) were squamous cell carcinoma and 5 cases were 
adenocarcinoma (10.86%). 
 The received specimens were categorised according to the site of 
presentation whether in upper 1/3rd, middle 1/3rd and lower 1/3rd and also 
categorized according to the morphological appearance.  
Table No V shows the distribution of cases according to the 
morphological appearance.  
Table No V 
S. No Type of Growth Number of Cases Percentage 
1 Proliferative / Fungating 39 84.78% 
2 Ulcerative 4 8.69% 
3 Infiltrative 3 6.52% 
 
 Most of the presented cases were in advanced stage with 
exophytic fungating growth on gross appearance (Fig 16,17).  
 Most of the cases presented in lower 1/3rd segment of esophagus 
(34 cases 73.91%). Relative distribution of squamous cell carcinoma 
according to site is shown in Table No V A.  
Table No V A 
S.
 N
o 
Site 
N
um
be
r 
of
 M
al
e 
ca
se
s 
Pe
rc
en
ta
ge
 
Number 
of 
Female 
Cases P
er
ce
nt
a
ge
 
To
ta
l 
Percentage
1 Upper 1/3rd 2 4.35% - - 2 4.35% 
2 Middle 1/3rd 4 8.69% 1 2.17% 5 10.86% 
3 Lower 1/3rd 19 41.305 15 32.60% 34 73.91% 
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Table No V B shows the relative distribution of squamous cell 
carcinoma in both sex.  
 
Table No V B 
Male Number of cases 25 60.97% 
Female Number of cases 16 39.03% 
 
 
Majority of patients who had squamous cell carcinoma were 
males (60.97%).  
Table No V C shows the relative distribution of squamous cell 
carcinoma according to differentiation.  
 
Table No V C 
 
Number of 
cases S. No 
Degree of 
differentiation 
Male Female
Total Percentage
1 Well differentiated SCC  19 7 26 63.41% 
2 Moderately differentiated SCC 8 5 13 31.707% 
3 Poorly differentiated SCC 2 0 2 4.88% 
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Fig 18 Well differentiated squamous cell carcinoma –Keratin pearl formation and  
intercellular bridges (H & E X100). 
 
 
 
 
 
 
 
 
 
 
Fig 18A High power view of above X400 ↑. 
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Fig 19 Moderately differentiated SCC – with intercellular bridges (H & E X400). 
 
 
 
 
 
 
 
 
 
Fig 20 Poorly differentiated SCC –large pleomorphic cells with high nuclear  
cytoplasmic ratio with brisk lymphocytic response.(H &E X400). 
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Fig 21 SCC with basisquamous features -basal cells with squamous differentiation  
           and retraction artefact (H & E X100). 
 
 
 
 
 
 
 
 
 
 
Fig 21A High power view of above X400 with Keratocysts. ↑. 
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Fig 22 Basaloid carcinoma –islands of basaloid cells with peripheral palisading and  
            cribriform pattern (H & E X100). 
 
 
 
 
 
 
 
 
 
 
Fig 22A Basaloid carcinoma – adenoid cystic spaces containing mucoid hyaline like  
              material (H & E X400). 
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Most of the adenocarcinomas occurred in males Table No VI 
shows the relative distribution of adenocarcinoma according to 
differentiation. 
Table No VI  
 
Number of casesS. 
No Degree of differentiation Male Female 
Total Percentage
1 Well differentiated adenocarcinoma 3 0 3 60% 
2 Moderately differentiated adenocarcinoma 1 0 1 20% 
3 Poorly differentiated adenocarcinoma 1 0 1 20% 
 
Most of the squamous cell carcinoma were well differentiated    
(26 cases –63.41%) (Fig 18). 
13 cases of squamous cell carcinoma were moderately 
differentiated (Fig 19) (13 cases-31.71%). 
Only 2 cases of squamous cell carcinoma were poorly 
differentiated (Fig 20) (4.88%).  
One poorly differentiated squamous cell carcinoma case had areas 
of basisquamoid picture and focal spindling. One moderately 
differentiated squamous cell carcinoma case had areas of basisquamous 
features. (Fig 21) One of the esophagectomy specimen had features of 
basaloid carcinoma (Fig 22) characterised by proliferation of oval to 
round, large pleomorphic basaloid cells with open pale chromatin 
pattern, small nuclei and scant cytoplasm arranged in solid and 
cribriform lobules often showing central necrosis, nests of tumor cells 
show peripheral palisading. 
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Fig 23 Poorly differentiated adenocarcinoma –diffuse infiltration of neoplastic cells,  
           with desmoplastic stroma (H & E X100). 
 
 
 
 
 
 
 
 
 
Fig 23A High power view of above X 400↑. 
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Fig 24 Barrett’s esophagus – Alcian blue (2.5) with PAS Positivity. 
 
 
 
 
 
 
 
 
Fig 24A High Power view of above X400- scattered  intensly blue staining goblet  
               cells of Barrett’s metaplastic epithelium ↑. 
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Fig 25 Intense nucleocytoplasmic immunoreactivity for S100 protein in malignant  
            melanoma X400. 
 
 
 
 
 
 
 
 
 
 
Fig 26 Sarcomatoid carcinoma exhibiting intense vimentin positivity.X100. 
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Fig 26A High power view of above X400↑. 
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Most of the adenocarcinomas were well differentiated except for 
two, one was moderately differentiated and the other Poorly 
differentiated. (Fig 23) 
In Barrett’s esophagus histochemistry with Alcian blue PAS was 
performed (Fig 24). Immunohistochemistry was performed in 2 doubtful 
cases and the results are shown in Table No VII. (Fig 25, 26) 
 
 
Table No VII 
S. No Cases  S100 Vimentin Cytokeratin EMA 
1 Sarcomatoid Carcinoma - + - - 
2 Malignant melanoma + - - - 
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DISCUSSION 
 
The present study as in the others and literature shows that 
esophageal lesions particularly malignant neoplasms are one of the 
commonest cancers occurring in the world. 
Barrett’s esophagus, as a result of GERD is now an accepted 
cause for further adenocarcinoma at lower end of esophagus. The 
following Table No VIII shows the incidence of esophageal neoplasm in 
our institution. 
Table No VIII 
 
Esophageal Carcinomas S. 
No Year 
Total 
No of 
Cancer 
patients Male Female Total P
er
ce
nt
a
ge
 
1 Jan 2000 to Dec 2000 397 37 4 41 10.327% 
2 Jan 2001 to Dec 2001 426 36 6 42 9.859% 
3 Jan 2002 to Dec 2002 511 47 6 53 10.371% 
4 Jan 2003 to Dec 2003 423 32 11 43 10.165% 
5 Jan 2004 to Dec 2004 385 24 16 40 10.389% 
6 Jan 2005 to Sep 2005 320 18 3 21 6.562% 
 
Between January 2000 and September 2005, 2462 cancer patients 
attended our institution and of them, 240 patients had esophageal 
cancers, which constitutes 9.748% of the cancer cases registered in our 
hospital. 
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The incidence of esophageal cancers is uniformly high in India 
with Kashmir falling in the Asian esophageal cancer belt having a 
maximum incidence of 43.6/lakh population and Bombay having an 
incidence of 15.2/lakh population. 
The case of cancer in the Eastern and Northern parts, is thought to 
be due to widely prevalent habit of drinking large quantity of scorching 
hot tea. According to Dr K Met and Bhansali SK, low rainfall and high 
salinity in the soil are also related to the increased incidence of 
esophageal cancers in Coastal Orissa and Karnataka. 
In the present study, as in the others, the incidence   of esophageal 
lesions is high in the age group of 51-60 yrs followed by 41-50yrs. Das 
et al 1970 had also reported a high incidence of esophageal cancers in 
this age group. In contrast, this age incidence is considerably lower than 
that reported in the western countries, where it is common in sixtees and 
seventees. 
In our study esophageal carcinomas occur more commonly in 
males, with male, female ratio of 8:1 in contrast with figures of 
Registrar-General of UK statistics of 1.5:1.0. 
In our study 90% of cases complained of dysphagia and most of 
them had Grade III or Grade IV dysphagia. About 70% of patients had 
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loss of weight and anorexia followed by regurgitation of food in 33% of 
cases. 
The figures come in well correlation with clinical evaluation 
conducted by Orringer et al and Sriram et al in Thanjavur March 2000, 
as shown in Table No IX 
Table No IX 
 
ORRINGER
(100 Cases) 
SRIRAM 
(82 Cases) 
PRESENT 
STUDY S. 
No SYMPTOMS 
No % No % No % 
1 Dysphagia 90 90% 82 100% 250 90.20%
2 Odynophagia 50 50% 26 31.7% 78 28.16%
3 Anorexia 48 48% 49 60% 152 54.87%
4 Regurgitation 30 30% 30 36.6% 90 32.49%
5 Hoarseness of voice 4 4% 3 3.6% 2 0.72% 
  
In our study 2 cases of well differentiated squamous cell 
carcinoma esophagus is seen in 20 yrs of age, clearly shows the role of 
environment, food habits, nutrition and stress in the emergence of 
malignant neoplasm at the younger age group. 
 Esophageal cancer is modulated by not one single factor, but 
rather a large number of factors such as smoking, alcohol drinking and 
food consumption10. The particular contributions of these factors to 
esophageal cancer may differ among areas or countries along with 
variation in exposure levels, both individually and in combination. 
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Smoking has been proved to be a major risk factor for several sites 
cancer such as nasal, oral and lung cancers. 
 
 Ethanol is not a carcinogen itself, but may promote 
carcinogenesis10   via, 1) Generation of free radical products during its 
metabolism, 2) solvent effects on tobacco and other carcinogens,          
3) Induction of microsomal enzymes involved in carcinogen 
metabolism, 4) Metabolism to acetaldehyde which has proven to be a 
carcinogen in animal experiments. 
 Since the alcohol consumption is different among areas of India 
and the levels of other risk factors also vary, alcohol has a different 
contribution to esophageal cancer among various areas of India. 
 Furthermore, eating food rapidly increased the risk, while 
frequent consumption of fresh fruit, fresh vegetables and eggs was 
associated with protection. Foods not chewed adequately could disrupt 
the mucosal lining of carcinogenesis and growth of lesions. 
 Nutritional factors have been implicated in the etiology of 
esophageal cancer. Evidence from epidemiological and experimental 
studies suggests that deficiency of micronutrients39 namely vitamin A, 
Zinc, Selenium and magnesium are associated with esophageal cancer. 
 Risk factor for squamous cell carcinoma of the esophagus have 
been identified such as tobacco, alcoholism, malnutrition, infection with 
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human papilloma virus. The risk factors associated with esophageal 
adenocarcinoma are less well defined.  
 
The most important epidemiological difference between 
squamous cell carcinoma and adenocarcinoma however, is the strong 
association between gastroesophageal reflux disease and 
adenocarcinoma2. The results of a population based controlled study 
suggest that symptomatic gastroesophageal reflux is a risk factor for 
esophageal adenocarcinoma.The frequency, severity and duration of 
reflux symptoms were positively associated with increased risk of 
adenocarcinoma. 
 Barrett’s esophagus is noted in 3% to 12% of patients with 
symptomatic GERD who undergo endoscopy with biopsy.  The 
definition of Barrett’s esophagus has been refined over the past 10 years. 
In studies published in the 1970s and 1980s,Barrett’s esophagus was 
commonly defined by the presence of atleast 2 to 3 cm of columnar 
epithelium in the lower esophagus.   This requirement avoided the 
diagnostic difficulties posed by the ‘normal’ occurrence of cardiac or 
fundic type epithelium in the distal esophagus. However more recent 
studies have found that only those patients with intestinal metaplasia, 
defined by the presence of acid mucin containing goblet cells, are at 
increased risk of developing dysplasia and adenocarcinoma, and as such, 
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the definition of Barrett’s esophagus has now become dependent upon 
identification of goblet cells.  
 
Recently the American college of Gastroenterology and its 
practice parameters committee provided a definition of Barrett’s 
esophagus “as a change in the esophageal epithelium of any length that 
can be recognised at endoscopy and is confirmed to have intestinal 
metaplasia by biopsy.”25 Thus the presence of goblet cells has become 
the accepted diagnostic criterion of this disease, regardless of the precise 
site of biopsy within the tubular esophagus. 
 Barrett’s esophagus (BE) is an acquired condition in which the 
squamous epithelium at the distal esophagus is replaced by metaplastic 
columnar epithelium. In general, BE results from severe esophageal 
mucosal injury by chronic gastroesophageal reflux disease25,34,41,43,51. 
Interest in BE mainly stems from its well established association with 
adenocarcinoma of the esophagus, a cancer whose incidence has 
increased rapidly in the last 3 decades. The recognition that cancer in 
BE predominantly originates from intestinal type columnar epithelium 
has led to the definition of BE by the presence of intestinal metaplasia 
(IM) in the esophagus34. The diagnosis of BE is readily achieved in 
patients who have long segments of IM by correlating endoscopic and 
histological findings. 
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 To avoid over diagnosis of BE, its presence is considered to be 
established only if endoscopic examination reveals a displacement of the 
squamocolumnar junction and if IM is detected by histological 
examination34. 
 Barrett’s esophagus is considered to be a disorder of the 
Caucasian male and therefore presumed to be rare among non-
Caucasian populations. However, recent reports indicate that its 
occurrence among populations of the developing countries might have 
been underestimated. Gadour and Ayoola study indicates that 0.3% of 
all patients undergoing endoscopy for various indications have BE. In 
their study 5 of 8 cases of BE were males. The number was too small for 
any firm conclusions regarding the sex distribution17. 
 It is clearly established that both the intestinal metaplasia 
associated with Barrett’s esophagus and its subsequent progression to 
esophageal adenocarcinoma are associated with pathologic gastro 
esophageal reflux. 
 Gastroesophageal reflux associated with the development of 
intestinal metaplasia is generally both severe and long standing, and is 
characterised by profound alterations in the esophageal luminal 
environment, including frequent and wide fluctuations in luminal PH 
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and high exposure to inflammatory components such as bile salts and 
proteolytic enzymes. 
 A large body of research over the past decade has outlined many 
of the genetic changes that are important in the metaplastic-dysplastic-
carcinoma progression of esophageal adenocarcinoma. Implicated 
genes, including those involved in cell signaling, cell cycle control, cell 
adhesion, and apoptosis are well characterised and their expression 
levels are known to be altered in esophageal carcinogenesis. 
 Endoscopic surveillance of patients with Barrett’s esophagus is 
recommended to detect malignancy at an early, potentially curable 
stage. However, it has been argued that surveillance is relatively 
ineffective and not very cost effective.  This has led to a search for risk 
factors that allows for better stratification of the patients according to 
their individual risk of developing adencarcinoma. 
 Not only the history of esophageal carcinoma but also risk factors 
for developing of such cancer could differ over time and from one 
region to another. Squamous cell carcinoma of the esophagus in the 
developed world is at least five times more common in men than in 
women, properly because men drink and smoke more37. 
 A diversity of begnin tumors and nonneoplastic masses can be 
seen in the esophagus. They are however mostly uncommon lesions, 
small and asymptomatic, whose importance lies in their distinction from 
malignant tumors. Most clinically apparent tumors grow or protrude into 
the lumen and thus appears as polyps at endoscopy. The differential 
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diagnosis of polypoid esophageal lesions25 is summarised in following 
Table No X. 
Differential diagnosis of polypoid esophageal Tumors 
 
Table No X 
 
LESION DISTINGUISHING FEATURES
Benign 
Squamous Papilloma 
Bland epithelium covering 
fibrovascular cores 
Fibrovascular Polyp 
Pedunculated mass of fibrous      
(+/- adipose) tissue found in upper 
esophagus. 
Inflammatory fibroid polyp Vascular fibroblastic tissue with mixed inflammation 
Submucosal tumors Leiomyoma, granular cell tumor most common 
Malignant 
Squamous cell carcinoma 
 
Especially verrucous variant 
Adenocarcinoma Infrequently polypoid 
Sarcomatoid carcinoma Atypical spindle cell stroma predominates 
Malignant melanoma Melanin pigmentation; junctional changes 
Sarcomas Rare, distinguish from carcinoma with spindle cell component 
Metastic tumors Occasionally produce polypoid mass 
 
In our study 81 cases of noncancerous lesion is observed in which 
42 cases are with squamous intra epithelial neoplasm (SIL) changes and 
14 cases show only normal esophageal epithelium and 14 cases with 
only fibrous tissue without the covering epithelium. 
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1 case of squamous papilloma showing benign squamous 
epithelium lining delicate connective tissue stalk is seen. Squamous 
papillomas are the most common benign epithelial esophageal neoplasm 
mostly arising in the distal esophagus appearing as small and sessile 
mass, usually solitary. 
  
They are rare lesion, noted in less than 0.04% of endoscopic 
examination and typically represent an incidental finding in 
asymptomatic patients, although larger lesions cause dysphagia. Several 
studies have identified HPV DNA in some squamous papilloma 
particularly HPV 6,11,16,18.44 
  
One case of fibromuscular polyp with intact overlying mucosa 
and core of mature fibrous tissue exhibiting foci of myxoid areas, and 
thin walled vessels is seen. 
  
Typically these polyps arise in the upper esophagus from the 
cricopharyngeal region and they present as elongated pedunculated mass 
that may range upto 20 cm in length. 
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Squamous cell carcinoma is the most common malignant tumor of 
esophagus worldwide. It affects predominantly men with peak incidence 
in 5th decade of life. Its incidence differs dramatically, however, in 
different countries with smoking, alcohol abuse, dietary exposure, 
genetic factors and HPV all suspected of playing etiological role. 
Esophageal cancer poses several general diagnostic task for surgical 
pathologist; 
 
Establish the diagnosis of malignancy, classifying the histological 
type and assessing prognostic factor. 
  
The recognition of esophageal malignancy in mucosal biopsy 
specimen is usually straightforward although the diagnostic features 
may be hidden by more abundant, inflamed, fibrotic or necrotic tissue. 
Cytological examination is an effective valuable adjunct. Diagnostic 
yield of combined endoscopic biopsy and brush cytology approaches 
100%42. 
  
In our study 176 cases of squamous cell carcinoma and 18 cases 
of Adenocarcinoma is initially diagnosed with endoscopic biopsy 
evaluation and the ratio between squamous cell carcinoma and 
adenocarcinoma is 8.2:1. 
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 This figures come in correlation with studies conducted by 
various author in the developing countries especially in south Asian 
countries. But in contrast the studies conducted by western people show 
an increased incidence of adenocarcinoma almost with 1:1 ratio, 
probably attributed to their changes in lifestyle, increased intake of 
alcohol, smoking, food habits etc. But our study correlates well with 
both south Asians as well as western research workers that both in SCC 
and Adenocarcinoma, the incidence is more common in male.  
 
Squamous cell carcinoma are usually located in the lower and 
midesophagus, only about 10% are found in cervical and upper thoracic 
region32,51. In accordance, in our study only 4.35% are found in cervical 
and 10.86% are found in middle and 73.91% are found in lower 
esophagus. 
  
At the time of diagnosis, most are advanced lesions with invasion 
into or beyond the muscularis propria.  In our study only one 
esophagectomy specimen revealed adjacent nodal metastasis. Grossly 
SCC usually present as  fungating, proliferative mass51 , in our study 
also 39 cases (84.78%) presented as fungating  proliferative mass . 
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Microscopically SCC are classified into well, moderate and 
poorly differentiated and any degree of differentiation may occur and 
variation within single tumour is common. In better differentiated 
lesions, mild nuclear atypia and cellular pleomorphism are accompanied 
by readily identified keratinisation, whereas in poorly differentiated 
tumors, keratinisation is sparse and cytological abnormalities more 
pronounced. 
One case of sarcomatoid carcinoma with biphasic histology 
exhibiting both carcinomatous and spindle cell components, on 
Immunohistochemistry revealed features of sarcoma with vimentin 
positivity.  
The assortment of names applied to this Tumor- Carcinosarcoma, 
pseudosarcoma, pseudosarcomatous squamous cell carcinoma, spindle 
cell carcinoma and polypoid carcinoma testifies to differing views of its 
histogenesis and biology. 
The predominant concept is that it originates by sarcomatous 
metaplasia of malignant epithelial cells. 
One case of basaloid squamous cell carcinoma with characteristic 
invasive lobules of basaloid cells with peripheral palisading, areas of 
necrosis and deposits of hyalinized basal lamina stroma, which tends to 
be deeply invasive, with frequent widespread metastases which is of 
poor prognosis was seen. 
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One case of adenosquamous carcinoma characterised by mixed 
glandular and squamous differentiation in more equal proportions is 
noted which is a rare aggressive neoplasm. One case of primary 
malignant melanoma characterised by basal   proliferation of benign 
melanocytes (Melanosis) with the stroma infiltrated by pigmented 
epithelioid and spindled cells in sheets was seen, which on 
Immunohistochemistry showed positivity for S100. 
 
Most adenocarcinomas develop in the lower third of esophagus, 
some may extend into the proximal stomach. Grosss appearance being 
flat irregular plaques to advanced fungating masses. Most are well or 
moderately differentiated. Intestinal type glandular formulation is 
common.  
 
The intestinal metaplastic epithelium of Barrett’s esophagus can 
be identified adjacent to the tumor in most cases, and epithelial 
dysplasia is a common coexisting feature. In some tumors however, no 
residual Barrett’s esophagus is seen, presumably because it has been 
overgrown by the carcinoma. 
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 CONCLUSION 
 
 The present study comprising of 277 esophageal biopsies and 46 
esophagectomy specimens suggest the following conclusions.  
1. The incidence of esophageal lesions is 9.75%  
2. Esophageal lesions are common in males, with Male: Female 
ratio of 2.2: 1 
3. Esophageal lesions both neoplastic and non neoplastic are 
common in the lower end of esophagus  
4. The habit of tobacco chewing along with betel nuts and leaves 
and consuming alcohol is considered to be major predisposing 
factor in our region 
5. Nonneoplastic esophageal lesions are more prevalent in 31-40 
years of age group. 
6. Neoplastic esophageal lesions are more prevalent in 51-60 yrs 
of age group. 
7. Most common presenting symptom is dysphagia observed in all 
the patients under study, followed by loss of weight and 
anorexia. 
8. Most of the cancers are of squamous cell origin. 
9. Barret’s esophagus is noted in 3.25% of patients with 
symptomatic GERD who undergo endoscopy with biopsy. 
10. Barret’s esophagus with dysplasia progress to adenocarcinoma. 
11. Immunohistochemistry remains in its place as final confirmative 
tool in doubtful cases.  
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APPENDIX    I 
 
 
Procedure of combined AB PH 2.5 PAS FOR ACID AND 
NEUTRAL MUCINS 
 
 Acid mucins and   neutral mucins are clearly separated by this 
technique. The rationale is that by first staining all acid mucins with 
Alcian Blue, those acid mucins which are also PAS positive will not 
react with the subsequent PAS reaction, neutral mucins alone will take 
up PAS stain. In this way a good colour distinction can be made 
between acid and neutral mucins. 
Preparation of Stains:  
a) Alcain Blue-1gm 3% Acetic acid –100cm3 
b) Schiff’s   Reagent- 1gm basic fuschin in 200cc boiling water 
i. 2gm Potassium metabisulfite 
ii. 2ml Concentrated HCL  
iii. Mix and add 2gm activated charcoal –filter and store 
at 4°C 
c) 1% aqueous periodic acid. 
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METHOD: 
1. Dewax sections and bring to water 
2. Alcian Blue solution     - 5 minutes 
3. Wash in distilled water  
4. 1% aqueous  periodic acid    - 5 minutes  
5. Rinse well in distilled water  
6. Schiff’s reagent      - 15 minutes 
7. Wash in running tap water    - 5-10 minutes 
8. Stain nuclei lightly with Harris Haematoxylin 
9. Differentiate as appropriate and blue. 
10. Wash in distilled water  
11. Rinse in absolute alcohol  
12. Clean in Xylene and mount as desired  
Results: 
Acid mucin   –  Blue 
Neutral mucin  –  Magenta 
 
 Mixtures of the above – the colour will develop on the dominant 
entity and will range from blue purple, through purple to a violet or 
magenta colour. 
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APPENDIX – II 
STANDARD HEMATOXYLIN AND EOSIN STAIN FOR 
PARAFFIN SECTIONS 
 
Method: 
1. De wax sections, hydrate through graded alcohols to water. 
2. Remove fixation pigments.  
3. Stain in an alum hematoxylin of choice for a suitable time. 
4. Wash well in running tap water until sections ‘blue’ for 5 
minutes or less. 
5. Differentiate in 1 percent acid alcohol (1 percent HCL in 70 
percent alcohol) for 5-10 sec. 
6. Wash well in tap water until sections are again ‘blue’ (10-15) 
minutes), or 
7. Blue by dipping in a alkaline solution (e.g. ammonia water), 
followed by a 5-min. tap water wash. 
8. Stain in 1 percent eosin Y for 10 min.  
9. Wash in running tap water for 1-5 min. 
10. Dehydrate through alcohols, clear and mount. 
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Results: 
 Nuclei   blue/black 
 Cytoplasm   Varying shades of pink 
 Muscle fibers  deep pink/red 
 Red blood cells  orange/red 
 Fibrin    deep pink 
 
Notes: 
 Note that structures and substances other than nuclei may be 
hematoxphilic to varying degrees. Examples include fungal hyphae, 
which are faintly hematoxyphilic, and calcium deposits, which are often 
deep blue- black. 
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